Biosimilars approved for hematology use: lessons from comparative efficacy studies and comparative analytical assessments.

求助中 20 由 tyche233 发布于 2026/8/17 10:37:05

DOI:10.1182/blood.2025031673
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1182/blood.2025031673

其它数据库

Abstract：Abstract: Biosimilars used in hematology have been at the forefront of biosimilar development since the first US approval in 2015 of a filgrastim product, with >80 now licensed by the US Foo

应助信息

等您来应助

上传文件

4小时前

Book学术机器人

2026/8/17 10:37:05 未找到该文献，机器人已退出，请等待人工下载

2026/8/17 10:37:05 Book学术AI机器人收到请求，开始寻找文献

2026/8/17 10:37:05 已向机器人发送请求

4小时前

tyche233 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyKLF4-induced upregulation of SOCS1 ameliorates myocardial ischemia/reperfusion injury by attenuating AC16 cardiomyocyte damage and enhancing M2 macrophage polarization